تالیفات

 

Proposed ocular Behcet therapeutic scoring and activity/chronicity ratio.

Authers: H. Chams, F. Shahram, F. Davatchi, M. Akbarian, F. Gharibdoost, A. Nadji, S. Chams

Abstract: The aim of this study is to propose a scoring system to determine the activity of the eyes, and to evaluate our medications in the treatment of ocular inflammation and vasculitis in Behect's disease (BD). Eleven activity and 5 chronicity (constant) parameters are scored from zero to 4 to consider the condition of each eye in Oculo-Behcet's disease. Both parameters are considered in our therapeutic scoring. The activity variables are: Episcleritis and/or ... سال انتشار: 1996
 

Cyclosporine in the treatment of severe ocular lesions of Behcet’s disease.

Authers: F. Gharibdoost, F. Shahram, F. Davatchi, H. Chams, M. Akbarian, A. Nadji

Abstract: Introduction: there are several reports of good effects of Cyclosporine A (Cs A) in the treatment of Behcet's disease (BD). We studied the long term effect, of A Cs A in a prospective open clinical trial on posterior uveitis (PU) and retinal vasculitis (RV) of BD. Materials & Methods: Twenty three patients with PU and / or RV diagnose as BD (according to the Iran and to the Japan criteria) ... سال انتشار: 1996
 

Proposed ocular Behcet therapeutic scoring & activity/chronicity ratio.

Authers: H. Chams, F. Shahram, F. Davatchi, M. Akbarian, F. Gharibdoost, A. Nadji, S. Chams

Abstract: Behcet’s Unite, Shariati Hospital the aim to propose a scoring system for the treatment of the ocular inflammation one vasculitis by our medications and to evaluate the state of the activity of the eye. Eleven activity and five chronicity (constant) parameters are scored from zero to four to consider the condition of each eye. The activity variables are: episcleritis &/or scleritis, anterior uveitis, hyalites, IMU, central periphlebitis &/or thrombosis, central periartertis, peripheral ... سال انتشار: 1996
 

Treatment of Ocular Lesions in Behcet’s Disease (Outcome Analysis of Six Different Therapeutic Methods).

Authers: Farhad Shahram

Abstract: Introduction: Ocular lesions are the major cause of morbidity in Behcet’s Disease. If not treated they usually progress toward severe loss of vision or blindness. Cytotoxic drugs are the main therapeutic arsenal used for this condition. Materials & Methods: In an open, non randomized control study, pulse Cyclophosphamide (PCP), low dose pulse cyclophosphamide (LDP), oral cyclophosphamide (OCP), weakly methotrexate (MTX), chlorambucil (CHL), and cyclosporine A (CYA) were used in a standard ... سال انتشار: 1996